Products/NAD+/NMN/NMN Injection
InjectableNMN-INJ

NMN Injection

100mg≥99.5% Purity

Injectable NMN formulation for direct parenteral administration. Each 100mg vial is manufactured under aseptic conditions. Designed for clinical protocols where maximum bioavailability and rapid cellular uptake are priorities.

Request a Quote

Pricing available for qualified medical professionals, clinics, and distributors.

Enquire NowView FAQ

Mechanism of Action

Injectable NMN bypasses gastrointestinal degradation entirely, delivering the NAD+ precursor directly to systemic circulation at near-100% bioavailability. NMN is then rapidly converted to NAD+ inside cells by NMNAT enzymes, supporting mitochondrial function, sirtuin activity, and DNA repair mechanisms.

Read the research

Clinical Benefits

  • 100% bioavailability via parenteral route
  • Immediate cellular uptake and effect
  • Accurate dosage control
  • 85% reported improvement in sleep quality in clinical observations

Specifications

RouteIM / SC administration
Bioavailability~100% (parenteral)
Purity≥99.5% (HPLC verified)
SterilityAseptic manufacturing

Storage & Handling

  • Store unreconstituted vials at 2–8°C
  • Protect from light
  • Use reconstituted solution within 24 hours
  • Do not freeze reconstituted solution

Reconstitution

Reconstitute per clinical protocol. Solution should be clear and colourless.

Related Products

For professional medical use only. Not for retail sale to the general public. Pricing available on request for qualified medical institutions and distributors.